Metastasis of Breast Tumor Cells to Brain Is Suppressed by Phenethyl Isothiocyanate in a Novel In Vivo Metastasis Model

PLoS ONE

Volumn 8, Issue 6, 2013, Pages

  Gupta, Parul ^a   Adkins, Chris ^a   Lockman, Paul ^a   Srivastava, Sanjay K ^a  

^a TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; PHENETHYL ISOTHIOCYANATE; VASCULOTROPIN; VASCULOTROPIN RECEPTOR; ANTINEOPLASTIC AGENT; ISOTHIOCYANIC ACID DERIVATIVE; LUCIFERASE; QUANTUM DOT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; BRAIN METASTASIS; BREAST CANCER; CANCER CELL; CANCER SURVIVAL; CELL COUNT; CELL INVASION; CELL MIGRATION; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; GROWTH INHIBITION; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PHARMACOLOGICAL BLOCKING; PROTEIN EXPRESSION; TREATMENT RESPONSE; TUMOR GROWTH; ANIMAL; BRAIN; BRAIN NEOPLASMS; DRUG EFFECTS; DRUG SCREENING; GENETIC TRANSFECTION; GENETICS; HEART VENTRICLE; KAPLAN MEIER METHOD; MAMMARY NEOPLASMS, EXPERIMENTAL; METABOLISM; NEOPLASM METASTASIS; NUDE MOUSE; ORAL DRUG ADMINISTRATION; PATHOLOGY; PATHOPHYSIOLOGY; SECONDARY; TUMOR CELL LINE;

MURINAE; MUS;

ADMINISTRATION, ORAL; ANIMALS; ANTINEOPLASTIC AGENTS; BRAIN; BRAIN NEOPLASMS; CELL LINE, TUMOR; FEMALE; HEART VENTRICLES; ISOTHIOCYANATES; KAPLAN-MEIER ESTIMATE; LUCIFERASES; MAMMARY NEOPLASMS, EXPERIMENTAL; MICE, NUDE; NEOPLASM METASTASIS; QUANTUM DOTS; TRANSFECTION; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84879533925     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0067278     Document Type: Article

References (59)

1. Mehlen P, Puisieux A, (2006) Metastasis: a question of life or death. Nat Rev Cancer 6: 449-458.
2. O'Shaughnessy J, (2005) Extending survival with chemotherapy in metastatic breast cancer. Oncologist 10Suppl 3: 20-29.
3. Jemal A, Bray F, (2011) Center MM, Ferlay J, Ward E, et al (2011) Global cancer statistics. CA Cancer J Clin 61: 69-90.
4. Chang EL, Lo S, (2003) Diagnosis and management of central nervous system metastases from breast cancer. Oncologist 8: 398-410.
5. Lassman AB, DeAngelis LM (2003) Brain metastases. Neurol Clin 21: 1-23, vii.
6. Frisk G, Svensson T, Backlund LM, Lidbrink E, Blomqvist P, et al. (2012) Incidence and time trends of brain metastases admissions among breast cancer patients in Sweden. Br J Cancer 106: 1850-1853.
7. Lin NU, Bellon JR, Winer EP, (2004) CNS metastases in breast cancer. J Clin Oncol 22: 3608-3617.
8. Weigelt B, Peterse JL, van 't Veer LJ, (2005) Breast cancer metastasis: markers and models. Nat Rev Cancer 5: 591-602.
9. Fidler IJ, Balasubramanian K, Lin Q, Kim SW, Kim SJ, (2010) The brain microenvironment and cancer metastasis. Mol Cells 30: 93-98.
10. Palmieri D, Bronder JL, Herring JM, Yoneda T, Weil RJ, et al. (2007) Her-2 overexpression increases the metastatic outgrowth of breast cancer cells in the brain. Cancer Res 67: 4190-4198.
11. Dieras V, Pierga JY, (2011) Brain metastasis of breast tumors and blood brain barrier. Bull Cancer 98: 385-389.
12. Pazaiti A, Fentiman IS, (2011) Basal phenotype breast cancer: implications for treatment and prognosis. Womens Health (Lond Engl) 7: 181-202.
13. Fidler IJ, (2011) The role of the organ microenvironment in brain metastasis. Semin Cancer Biol 21: 107-112.
14. Brown JM, Giaccia AJ, (1998) The unique physiology of solid tumors: opportunities (and problems) for cancer therapy. Cancer Res 58: 1408-1416.
15. Stewart PA, Hayakawa K, Farrell CL, Del Maestro RF, (1987) Quantitative study of microvessel ultrastructure in human peritumoral brain tissue. Evidence for a blood-brain barrier defect. J Neurosurg 67: 697-705.
16. Yano S, Shinohara H, Herbst RS, Kuniyasu H, Bucana CD, et al. (2000) Expression of vascular endothelial growth factor is necessary but not sufficient for production and growth of brain metastasis. Cancer Res 60: 4959-4967.
17. Palmer S, (1985) Diet, nutrition, and cancer. Prog Food Nutr Sci 9: 283-341.
18. Boggs DA, Palmer JR, Wise LA, Spiegelman D, Stampfer MJ, et al. (2010) Fruit and vegetable intake in relation to risk of breast cancer in the Black Women's Health Study. Am J Epidemiol 172: 1268-1279.
19. Lee SA, Fowke JH, Lu W, Ye C, Zheng Y, et al. (2008) Cruciferous vegetables, the GSTP1 Ile105Val genetic polymorphism, and breast cancer risk. Am J Clin Nutr 87: 753-760.
20. Butler LM, Wu AH, Wang R, Koh WP, Yuan JM, et al. (2010) A vegetable-fruit-soy dietary pattern protects against breast cancer among postmenopausal Singapore Chinese women. Am J Clin Nutr 91: 1013-1019.
21. Daxenbichler ME, VanEtten CH, (1977) Glucosinolates and derived products in cruciferous vegetables: gas-liquid chromatographic determination of the aglucon derivatives from cabbage. J Assoc Off Anal Chem 60: 950-953.
22. Brown KK, Hampton MB, (2011) Biological targets of isothiocyanates. Biochim Biophys Acta 1810: 888-894.
23. Hecht SS, (2000) Inhibition of carcinogenesis by isothiocyanates. Drug Metab Rev 32: 395-411.
24. Wu XJ, Hua X, (2007) Targeting ROS: selective killing of cancer cells by a cruciferous vegetable derived pro-oxidant compound. Cancer Biol Ther 6: 646-647.
25. Cheung KL, Kong AN, (2010) Molecular targets of dietary phenethyl isothiocyanate and sulforaphane for cancer chemoprevention. AAPS J 12: 87-97.
26. Jakubikova J, Cervi D, Ooi M, Kim K, Nahar S, et al. (2011) Anti-tumor activity and signaling events triggered by the isothiocyanates, sulforaphane and phenethyl isothiocyanate, in multiple myeloma. Haematologica 96: 1170-1179.
27. Gao N, Budhraja A, Cheng S, Liu EH, Chen J, et al. (2011) Phenethyl isothiocyanate exhibits antileukemic activity in vitro and in vivo by inactivation of Akt and activation of JNK pathways. Cell Death Dis 2: e140.
28. Wu CL, Huang AC, Yang JS, Liao CL, Lu HF, et al. (2011) Benzyl isothiocyanate (BITC) and phenethyl isothiocyanate (PEITC)-mediated generation of reactive oxygen species causes cell cycle arrest and induces apoptosis via activation of caspase-3, mitochondria dysfunction and nitric oxide (NO) in human osteogenic sarcoma U-2 OS cells. J Orthop Res 29: 1199-1209.
29. Yang MD, Lai KC, Lai TY, Hsu SC, Kuo CL, et al. (2010) Phenethyl isothiocyanate inhibits migration and invasion of human gastric cancer AGS cells through suppressing MAPK and NF-kappaB signal pathways. Anticancer Res 30: 2135-2143.
30. Conaway CC, Jiao D, Kohri T, Liebes L, Chung FL, (1999) Disposition and pharmacokinetics of phenethyl isothiocyanate and 6-phenylhexyl isothiocyanate in F344 rats. Drug Metab Dispos 27: 13-20.
31. Wu X, Zhu Y, Yan H, Liu B, Li Y, et al. (2010) Isothiocyanates induce oxidative stress and suppress the metastasis potential of human non-small cell lung cancer cells. BMC Cancer 10: 269.
32. Gupta P, Srivastava SK, (2012) Anti-tumor activity of phenethyl isothiocyanate in HER2 positive breast cancer models. BMC Med 10: 80.
33. Kandala PK, Srivastava SK (2012) Diindolylmethane mediated Gli1 Suppression Induces Anoikis in Ovarian Cancer cells in vitro and blocks tumor formation ability in vivo. J Biol Chem.
34. Kandala PK, Srivastava SK, (2012) Regulation of macroautophagy in ovarian cancer cells in vitro and in vivo by controlling glucose regulatory protein 78 and AMPK. Oncotarget 3: 435-449.
35. Yoneda T, Williams PJ, Hiraga T, Niewolna M, Nishimura R, (2001) A bone-seeking clone exhibits different biological properties from the MDA-MB-231 parental human breast cancer cells and a brain-seeking clone in vivo and in vitro. J Bone Miner Res 16: 1486-1495.
36. Palmieri D, Lockman PR, Thomas FC, Hua E, Herring J, et al. (2009) Vorinostat inhibits brain metastatic colonization in a model of triple-negative breast cancer and induces DNA double-strand breaks. Clin Cancer Res 15: 6148-6157.
37. Lockman PR, Mittapalli RK, Taskar KS, Rudraraju V, Gril B, et al. (2010) Heterogeneous blood-tumor barrier permeability determines drug efficacy in experimental brain metastases of breast cancer. Clin Cancer Res 16: 5664-5678.
38. Conley FK, (1979) Development of a metastatic brain tumor model in mice. Cancer Res 39: 1001-1007.
39. Sahu RP, Batra S, Srivastava SK, (2009) Activation of ATM/Chk1 by curcumin causes cell cycle arrest and apoptosis in human pancreatic cancer cells. Br J Cancer 100: 1425-1433.
40. Boreddy SR, Sahu RP, Srivastava SK, (2011) Benzyl isothiocyanate suppresses pancreatic tumor angiogenesis and invasion by inhibiting HIF-alpha/VEGF/Rho-GTPases: pivotal role of STAT-3. PLoS One 6: e25799.
41. Tsukada Y, Fouad A, Pickren JW, Lane WW, (1983) Central nervous system metastasis from breast carcinoma. Autopsy study. Cancer 52: 2349-2354.
42. Coleman RE, (2012) Bone cancer in 2011: Prevention and treatment of bone metastases. Nat Rev Clin Oncol 9: 76-78.
43. Jeong J, Lee KS, Choi YK, Oh YJ, Lee HD, (2011) Preventive effects of zoledronic acid on bone metastasis in mice injected with human breast cancer cells. J Korean Med Sci 26: 1569-1575.
44. Tsao MN, Lloyd N, Wong RK, Chow E, Rakovitch E, et al. (2012) Whole brain radiotherapy for the treatment of newly diagnosed multiple brain metastases. Cochrane Database Syst Rev 4: CD003869.
45. Padovani L, Muracciole X, Regis J, (2012) gamma knife radiosurgery of brain metastasis from breast cancer. Prog Neurol Surg 25: 156-162.
46. Liu XL, Peng CW, Chen C, Yang XQ, Hu MB, et al. (2011) Quantum dots-based double-color imaging of HER2 positive breast cancer invasion. Biochem Biophys Res Commun 409: 577-582.
47. Claffey KP, Robinson GS, (1996) Regulation of VEGF/VPF expression in tumor cells: consequences for tumor growth and metastasis. Cancer Metastasis Rev 15: 165-176.
48. Li X, Dang X, Sun X, (2012) Expression of survivin and VEGF-C in breast cancer tissue and its relation to lymphatic metastasis. Eur J Gynaecol Oncol 33: 178-182.
49. De Luca A, Lamura L, Gallo M, Maffia V, Normanno N, (2012) Mesenchymal stem cells-derived interleukin-6 and vascular endothelial growth factor promote breast cancer cell migration. J Cell Biochem 113: 3363-3370.
50. Xu C, Shen G, Chen C, Gelinas C, Kong AN, (2005) Suppression of NF-kappaB and NF-kappaB-regulated gene expression by sulforaphane and PEITC through IkappaBalpha, IKK pathway in human prostate cancer PC-3 cells. Oncogene 24: 4486-4495.
51. Wang XH, Cavell BE, Syed Alwi SS, Packham G, (2009) Inhibition of hypoxia inducible factor by phenethyl isothiocyanate. Biochem Pharmacol 78: 261-272.
52. Lau SK, Shields DJ, Murphy EA, Desgrosellier JS, Anand S, et al. (2012) EGFR-Mediated Carcinoma Cell Metastasis Mediated by Integrin alphavbeta5 Depends on Activation of c-Src and Cleavage of MUC1. PLoS One 7: e36753.
53. Nie F, Yang J, Wen S, An YL, Ding J, et al. (2012) Involvement of epidermal growth factor receptor overexpression in the promotion of breast cancer brain metastasis. Cancer 118: 5198-5209.
54. Nickerson NK, Mohammad KS, Gilmore JL, Crismore E, Bruzzaniti A, et al. (2012) Decreased Autocrine EGFR Signaling in Metastatic Breast Cancer Cells Inhibits Tumor Growth in Bone and Mammary Fat Pad. PLoS One 7: e30255.
55. Kim JH, Xu C, Keum YS, Reddy B, Conney A, et al. (2006) Inhibition of EGFR signaling in human prostate cancer PC-3 cells by combination treatment with beta-phenylethyl isothiocyanate and curcumin. Carcinogenesis 27: 475-482.
56. Fokstuen T, Wilking N, Rutqvist LE, Wolke J, Liedberg A, et al. (2000) Radiation therapy in the management of brain metastases from breast cancer. Breast Cancer Res Treat 62: 211-216.
57. Boogerd W, Vos VW, Hart AA, Baris G, (1993) Brain metastases in breast cancer; natural history, prognostic factors and outcome. J Neurooncol 15: 165-174.
58. Patanaphan V, Salazar OM, Risco R, (1988) Breast cancer: metastatic patterns and their prognosis. South Med J 81: 1109-1112.
59. Ji Y, Kuo Y, Morris ME, (2005) Pharmacokinetics of dietary phenethyl isothiocyanate in rats. Pharm Res 22: 1658-1666.